GSK Plc (GSK)
50.39
0.00 (0.00%)
USD |
NYSE |
Jan 12, 16:00
50.35
-0.04
(-0.08%)
Pre-Market: 20:00
GSK Research and Development Expense (Quarterly): 2.124B for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| AstraZeneca PLC | 3.530B |
| Biodexa Pharmaceuticals Plc | -- |
| AnaptysBio, Inc. | 31.27M |
| NuCana Plc | 2.928M |
| Mereo BioPharma Group Plc | 4.244M |